Challenging exchange rate makes Novozymes downgrade guidance

Danish enzyme producer Novozymes exits this year's second quarter slightly weaker than expected and is now downgrading its full-year guidance in DKK. Meanwhile, Bioenergy shows growth.

Photo: Novozymes/ PR

Novozymes emerged from this year's second quarter slightly weaker than expected by analysts, and the company is now downgrading its forecast for sales growth in Danish currency from 3-6 percent to 1-4 percent.

CEO Peder Holk Nielsen explains in the interim report that the downgrade is solely due to challenging exchange rate markets.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from EnergyWatch

Further reading

Related articles

Latest News

See all jobs